0Webinar: The Global Use of Medicines 2024The webinar is being recorded and will be available on-demand at the same link after the live session. For an enhanced view, click the small box located in the gray frame above the slide window. Find the resource list located at the bottom of your screen. You may ask a question at any time by clicking on the Q&A icon and submitting.If you are not seeing the slides at any point, please refresh your browser.A few important notes and reminders before we begin:Q&AEnlarge live viewFrozen screenDownload resourcesView on-demandCopyright © 2024 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States and various other countries.OUTLOOK TO 2028The Global Use of Medicines 20243 1 J a n u a r y 2 0 2 42+ 9:00 – 9:05 a.m.Welcome and IntroductionsMurray Aitken, Executive DirectorIQVIA Institute for Human Data Science+ 9:05 – 9:30 a.m.Global outlook and driversMichael Kleinrock, Research DirectorIQVIA Institute for Human Data Science+ 9:30 – 10:20 a.m.Regional highlights• United States – Elyse Muñoz• Europe, Middle East, Africa – Sarah Rickwood• China – Howard Chen • Japan – Alan Thomas• Latin America – Sydney Clark+ 10:20 – 10:30 a.m.Moderated discussion+ 10:30 a.m.CloseAgenda3SpeakersElyse MuñozDirector, Thought LeadershipIQVIA U.S.Sydney ClarkVP, Consulting Services IQVIA LATAMHoward ChenManaging Principal IQVIA ChinaSarah RickwoodVP, Thought Leadership IQVIA EMEAAlan ThomasSenior Director, Thought Leadership IQVIA JapanMurray AitkenExecutive DirectorIQVIA Institute for Human Data ScienceMichael KleinrockResearch DirectorIQVIA Institute for Human Data Science4Global outlook and drivers51,2711,3061,4461,4851,6071,7361,8681,9852,1072,2383116832829131212131,2001,4001,6001,8002,0002,2002,4002019202020212022202320242025202620272028Incremental spend for COVID-19 vaccines & therapeuticsCurrent outlook excluding COVID vaccinesPre-COVID-19 outlook-62-53-75-444719638661789410315116718419119820521331651637581869196-59661261863064686709131,203-2E+1102E+114E+116E+118E+111E+121.2E+121.4E+122019202020212022202320242025202620272028Cumulative difference, US$ BillionCumulative difference in non-COVID spending from pre-COVID-19 levelsCumulative Covid-19 vaccine spendingCumulative COVID-19 therapeuticsTotal cumulative difference from pre-COVID-19 levelsChanges in the historical and projected global medicine spending model due to COVID-19, 2019–2028, US$BnGlobal spending, including COVID-19 vaccines and therapeutics, is forecast to exceed pre-pandemic outlook by $1.2Tn to 2028Source: IQVIA Market Prognosis, Sep 2023; IQVIA Institute, Dec 2023.Global Use of Medicines 2024: Outlook to 2028. Report by the IQVIA Institute for Human Data Science. COVID-19 disruption impact: +$894Bn 2020–2028COVID-19 vaccine spending: $213Bn($190–$230Bn)Spending outlook change due to COVID-19: $1,203Bn, 2020–2028=+COVID-19 therapeutics: $96 Billion ($85-115Bn)+6-2%0%2%4%6%8%10%12%14...
